TY - JOUR
T1 - Endovascular Treatment for Stroke Due to Occlusion of Medium or Distal Vessels
AU - DISTAL Investigators
AU - Psychogios, Marios
AU - Brehm, Alex
AU - Ribo, Marc
AU - Rizzo, Federica
AU - Strbian, Daniel
AU - Räty, Silja
AU - Arenillas, Juan F.
AU - Martínez-Galdámez, Mario
AU - Hajdu, Steven D.
AU - Michel, Patrik
AU - Gralla, Jan
AU - Piechowiak, Eike I.
AU - Kaiser, Daniel P.O.
AU - Puetz, Volker
AU - Van Den Bergh, Frans
AU - De Raedt, Sylvie
AU - Bellante, Flavio
AU - Dusart, Anne
AU - Hellstern, Victoria
AU - Khanafer, Ali
AU - Parrilla, Guillermo
AU - Morales, Ana
AU - Kirschke, Jan S.
AU - Wunderlich, Silke
AU - Fiehler, Jens
AU - Thomalla, Götz
AU - Lemmens, Robin
AU - Peluso, Jo P.
AU - Bolognese, Manuel
AU - Von Hessling, Alexander
AU - Van Es, Adriaan
AU - Kruyt, Nyika D.
AU - Coutinho, Jonathan M.
AU - Castaño, Carlos
AU - Minnerup, Jens
AU - Van Zwam, Wim
AU - Dhondt, Elisabeth
AU - Nolte, Christian H.
AU - MacHi, Paolo
AU - Loehr, Christian
AU - Mattle, Heinrich P.
AU - Buhk, Jan Hendrik
AU - Kaesmacher, Johannes
AU - Dobrocky, Tomas
AU - Papanagiotou, Panagiotis
AU - Alonso, Angelika
AU - Holtmannspoetter, Markus
AU - Zini, Andrea
AU - Renieri, Leonardo
AU - Keil, Fee
N1 - Publisher Copyright:
© 2025 Massachusetts Medical Society.
PY - 2025/4/10
Y1 - 2025/4/10
N2 - Background Endovascular treatment (EVT) of stroke with large-vessel occlusion is known to be safe and effective. The effect of EVT for occlusion of medium or distal vessels is unclear. Methods We randomly assigned participants with an isolated occlusion of medium or distal vessels (occlusion of the nondominant or codominant M2 segment of the middle cerebral artery [MCA]; the M3 or M4 segment of the MCA; the A1, A2, or A3 segment of the anterior cerebral artery; or the P1, P2, or P3 segment of the posterior cerebral artery) to receive EVT plus best medical treatment or best medical treatment alone within 24 hours after the participant was last seen to be well. The primary outcome was the level of disability at 90 days, as assessed with the modified Rankin scale score. Results A total of 543 participants (women, 44%; median age, 77 years) were included in the analysis: 271 were assigned to receive EVT plus best medical treatment and 272 to receive best medical treatment alone. The median score on the National Institutes of Health Stroke Scale (range, 0 to 42, with higher scores indicating more severe symptoms) at admission was 6 (interquartile range, 5 to 9). Intravenous thrombolysis was given to 65.4% of the participants. The predominant occlusion locations were the M2 segment (in 44.0% of the participants), M3 segment (in 26.9%), P2 segment (in 13.4%), and P1 segment (in 5.5%). In the comparison between EVT plus best medical treatment and best medical treatment alone, no significant difference in the distribution of modified Rankin scale scores was observed at 90 days (common odds ratio for improvement in the score, 0.90; 95% confidence interval, 0.67 to 1.22; P=0.50). All-cause mortality was similar in the two groups (15.5% with EVT plus best medical treatment and 14.0% with best medical treatment alone), as was the incidence of symptomatic intracranial hemorrhage (5.9% and 2.6%, respectively). Conclusions In persons with stroke with occlusion of medium or distal vessels, EVT did not result in a lower level of disability or a lower incidence of death than best medical treatment alone.
AB - Background Endovascular treatment (EVT) of stroke with large-vessel occlusion is known to be safe and effective. The effect of EVT for occlusion of medium or distal vessels is unclear. Methods We randomly assigned participants with an isolated occlusion of medium or distal vessels (occlusion of the nondominant or codominant M2 segment of the middle cerebral artery [MCA]; the M3 or M4 segment of the MCA; the A1, A2, or A3 segment of the anterior cerebral artery; or the P1, P2, or P3 segment of the posterior cerebral artery) to receive EVT plus best medical treatment or best medical treatment alone within 24 hours after the participant was last seen to be well. The primary outcome was the level of disability at 90 days, as assessed with the modified Rankin scale score. Results A total of 543 participants (women, 44%; median age, 77 years) were included in the analysis: 271 were assigned to receive EVT plus best medical treatment and 272 to receive best medical treatment alone. The median score on the National Institutes of Health Stroke Scale (range, 0 to 42, with higher scores indicating more severe symptoms) at admission was 6 (interquartile range, 5 to 9). Intravenous thrombolysis was given to 65.4% of the participants. The predominant occlusion locations were the M2 segment (in 44.0% of the participants), M3 segment (in 26.9%), P2 segment (in 13.4%), and P1 segment (in 5.5%). In the comparison between EVT plus best medical treatment and best medical treatment alone, no significant difference in the distribution of modified Rankin scale scores was observed at 90 days (common odds ratio for improvement in the score, 0.90; 95% confidence interval, 0.67 to 1.22; P=0.50). All-cause mortality was similar in the two groups (15.5% with EVT plus best medical treatment and 14.0% with best medical treatment alone), as was the incidence of symptomatic intracranial hemorrhage (5.9% and 2.6%, respectively). Conclusions In persons with stroke with occlusion of medium or distal vessels, EVT did not result in a lower level of disability or a lower incidence of death than best medical treatment alone.
UR - https://www.scopus.com/pages/publications/105003472567
U2 - 10.1056/NEJMoa2408954
DO - 10.1056/NEJMoa2408954
M3 - Article
C2 - 39908430
AN - SCOPUS:105003472567
SN - 0028-4793
VL - 392
SP - 1374
EP - 1384
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 14
ER -